Author:
Tolani Musliu Adetola,Agbo Christian A.,Paciorek Alan,Umar Shehu S.,Ojewola Rufus W.,Mohammed Faruk,Kaninjing Ernie,Ahmed Muhammed,DeBoer Rebecca
Abstract
Abstract
Background
Prostate cancer mortality rates are high in Nigeria. While prostate cancer is highly curable with early detection and effective multidisciplinary management, the quality of care is suboptimal in this setting. Sustainable delivery of high-quality care for patients with localized prostate cancer is needed to save more lives. To inform future interventions to improve care, this study aimed to identify barriers and facilitators that influence prostate cancer detection and management in Nigeria.
Methods
Six focus group discussions (FGDs), stratified by stakeholders were conducted with a purposive sample of prostate cancer patients (n = 19), caregivers (n = 15), and healthcare providers (n = 18), in two academic tertiary hospitals in northern and southern Nigeria. A discussion guide organized based on the socio-ecological model was used. FGDs were recorded, transcribed, and analysed using the framework technique.
Results
Barriers and facilitators were identified at the individual, interpersonal, and organizational levels. Barriers to detection included limited knowledge and misperceptions among patients, caregivers, and community-based non-specialist healthcare providers, and limitations of centralized opportunistic screening; while facilitators included the potential for religious institutions to encourage positive health-seeking behaviour. Barriers to management included non-uniformity in clinical guideline usage, treatment abandonment amidst concerns about treatment and survival, absence of patient interaction platforms and follow-up support systems, difficulty in navigating service areas, low health insurance coverage and limited financial resource of patients. Facilitators of management included the availability of resource stratified guidelines for prostate cancer management and the availability of patient peers, caregivers, nurses, and medical social workers to provide correct medical information and support patient-centred services. Participants also provided suggestions that could help improve prostate cancer detection and management in Nigeria.
Conclusion
This study identified multiple determinants affecting the detection and management of localized prostate cancer. These findings will inform the refinement of implementation strategies to improve the quality of prostate cancer care in Nigeria.
Funder
Prostate Cancer Foundation – Pfizer Health Equity Challenge Award
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Nigerian National System of Cancer Registries. Cancer incidence in Nigeria: GLOBOCAN 2012 report. Newsl Nigerian Natl Syst Cancer Registries. 2014;1–10.
2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
3. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. 2020. pp. 1–2. https://gco.iarc.fr/today/data/factsheets/cancers/27-Prostate-fact-sheet.pdf.
4. Klein EA. Prostate cancer: Risk stratification and choice of initial treatment. Up To Date. 2021 [cited 2021 Apr 7]. pp. 1–31. https://www.uptodate.com/contents/prostate-cancer-risk-stratification-and-choice-of-initial-treatment?search=clinically Localized prostate cancer&source = search_result&selectedTitle = 7 ~ 150&usage_type = default&display_rank = 7.
5. Federal Ministry of Health. National Cancer Control Plan 2018–2022. 1st ed. Abuja, Nigeria: Federal Ministry of Health; 2022. pp. 1–67.